Close Menu

NEW YORK – With the COVID-19 pandemic expected to worsen in the US in the coming weeks, and testing capacity still playing catch-up, Emergency Use Authorizations from the US Food and Drug Administration have reached an inflection point.

Late last week the first two tests from the private sector were granted EUA, and early this week the FDA loosened its guidelines to make it easier for commercially developed tests to receive EUA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.